4//SEC Filing
REXAHN PHARMACEUTICALS, INC. 4
Accession 0001140361-17-015713
$IRDCIK 0001228627operating
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:26 PM ET
Size
9.6 KB
Accession
0001140361-17-015713
Insider Transaction Report
Form 4
Ahn Chang Ho
DirectorChairman & CEO
Transactions
- Sale
Common Stock
2017-04-10$0.70/sh−250,000$175,375→ 6,010,000 total - Exercise/Conversion
Common Stock
2017-04-10$0.31/sh+250,000$77,500→ 6,260,000 total - Exercise/Conversion
Stock Option (right to purchase)
2017-04-10−250,000→ 0 totalExercise: $0.31Exp: 2023-03-01→ Common Stock (250,000 underlying)
Holdings
- 500,000(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2016.
- [F2]The price of $0.7015 per share represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.70 to $0.709 per share, inclusive. The reporting person undertakes to provide upon request of the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F4]The options vested and became exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015 and 100,000 on March 1, 2016.
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001228627
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 5:26 PM ET
- Size
- 9.6 KB